Skip to content
  • CONTACT
  • SUBSCRIBE
FacebookTwitterInstagramPinterestLinkedIn
Voyageur Pharmaceuticals Logo Voyageur Pharmaceuticals Logo Voyageur Pharmaceuticals Logo
  • OUR COMPANY
    • Our Company
    • Corporate Strategy
    • Officers & Directors
    • CEO’s Posts
    • Responsible Mining
  • PHARMACEUTICALS
    • Manufacturing Facilities
    • Our Products
    • Barium & Iodine Contrast Market and Sales Strategy
  • C60 THERAPEUTICS
    • C60 – What Is it?
      • C60
      • Information Links
      • Technical Reports
    • C60 Therapeutics
      • Natural Health Products
      • Radiographic Drug Development
      • Drug Development
  • OUR PROPERTIES
    • Our Properties
    • Lithium & Iodine
    • Frances Creek High Grade Discovery
    • Jubilee Mountain
    • Pedley Mountain
    • US Assets
    • Geology & Reports
    • Project Gallery
  • INVESTORS CENTRE
    • Investors Centre
    • Lithium & Iodine
    • Barite
    • Capital Structure
    • Ownership Opportunity
    • Corporate Presentations
    • Why Invest?
    • Common Questions
  • NEWS
  • CONTACT

Voyageur Announces New CFO, Issuance of Shares and Warrants to Extinguish Debt, and Issuance of Stock Options

Voyageur Announces New CFO, Issuance of Shares and Warrants to Extinguish Debt, and Issuance of Stock Options

brent_adm2020-02-24T09:49:07-07:00

Office: + 587 779 6166
info@voyageurminerals.ca

Suite 255, 339 50th Avenue SE
Calgary, Alberta T2G 2B3

Privacy Policy | Disclaimer

Go to Top